INTERNATIONAL PATENT: TALLAC THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER USING ANTI-CD22 ANTIBODY OLIGONUCLEOTIDE CONJUGATES"

GENEVA, April 21 -- TALLAC THERAPEUTICS, INC. (866 Malcolm Road, Suite 100Burlingame, CA 94010) filed a patent application (PCT/US2024/051054) for "METHODS OF TREATING CANCER USING ANTI-CD22 ANTIBODY OLIGONUCLEOTIDE CONJUGATES" on Oct 11, 2024. With publication no. WO/2025/081048, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WAN, Hong, I. (c/o Tallac Therapeutics, Inc.866 Malcolm Road, Suite 100Burlingame, CA 94010), HARRABI, Ons (c/o Tallac Therapeutics, Inc.866 Malcolm Road, Suite 100Burlingame, CA 94010), HELLER, Ke...